{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:37:46Z","timestamp":1769600266038,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/adm.0000000000000081","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T15:35:09Z","timestamp":1413300909000},"page":"476-478","source":"Crossref","is-referenced-by-count":10,"title":["Combined Abuse of Clonidine and Amitriptyline in a Patient on Buprenorphine Maintenance Treatment"],"prefix":"10.1097","volume":"8","author":[{"given":"J. Paul","family":"Seale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trent","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika J.","family":"Sigman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Aaron","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"R1-14-20210126","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0740-5472(97)00309-7","article-title":"Clondidine use and abuse among methadone program applicants and patients.","volume":"15","author":"Beuger","year":"1998","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"R2-14-20210126","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/ALN.0b013e318238fea0","article-title":"Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active.","volume":"115","author":"Brown","year":"2011","journal-title":"Anesthesiology"},{"issue":"9","key":"R5-14-20210126","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.110.033878","article-title":"CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance.","volume":"38","author":"Claessens","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"13","key":"R6-14-20210126","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/jama.1978.03290130066024","article-title":"Abuse of amitriptyline.","volume":"240","author":"Cohen","year":"1978","journal-title":"JAMA"},{"issue":"2","key":"R8-14-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1010375727768","article-title":"Clonidine abuse among opiate addicts.","volume":"72","author":"Dennison","year":"2001","journal-title":"Psychiatr Q"},{"issue":"10","key":"R9-14-20210126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.","volume":"349","author":"Fudala","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"R10-14-20210126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addictiona clinical perspective.","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"R11-14-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000139533","article-title":"Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes.","volume":"55","author":"Olesen","year":"1997","journal-title":"Pharmacology"},{"issue":"1","key":"R13-14-20210126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.paf.0000154111.69255.ab","article-title":"Amitriptyline abuse and misuse.","volume":"26","author":"Prahlow","year":"2005","journal-title":"Am J Forensic Med Pathol"},{"issue":"12","key":"R14-14-20210126","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1176\/ajp.140.12.1625","article-title":"Four cases of clonidine abuse.","volume":"140","author":"Schaut","year":"1983","journal-title":"Am J Psychiatry"},{"issue":"2","key":"R15-14-20210126","first-page":"136","article-title":"Clonidine as a drug of abuse.","volume":"8","author":"Sharma","year":"1995","journal-title":"J Am Board Fam Pract"},{"issue":"5","key":"R17-14-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses.","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"R18-14-20210126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphinenaloxone diversion, misuse, and illicit use: an international review.","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr Drug Abuse Rev"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000000081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:57:32Z","timestamp":1620943052000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201411000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000000081","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}